Dr. Shmmon Ahmad

About

Dr. Shmmon Ahmad is currently serving as an Associate Professor at M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India UGC Grade-I, NBA, NAAC A++) NIRF Rank 26. He earned his Ph.D. in 2023, M.Pharm in 2014 and B.Pharm in 2011. He was honoured by the Governor of Punjab at Chandigarh College of Pharmacy, Mohali, (recognized as a SIRO by the Ministry of Science & Technology, Govt of India). Dr. Ahmad have more than 9 years of valuable experience in academia and research, working with both undergraduate and postgraduate programs. His professional journey also includes 2.5 years as a QA Officer at Ind-Swift Ltd., Mohali, Punjab (certified by MHRA-UK, TGA-Australia, EMEA-Europe, and WHO) and 1 year of experience at Crescent Therapeutic Limited, Baddi, H.P. (a WHO-GMP certified unit). Furthermore, Dr. Ahmad has made significant contributions to the field of pharmacy by authoring over 35 research and review papers, publishing & granted 20 Patents, and Autor/Editor 8 Books within the pharmacy domain.

Employment

• Maharishi Markandeshwar University, Mullana Associate Professor
  2025 - Present
• Glocal University Associate Professor
  2023 - 2025
• Glocal University Assistant Professor
  2017 - 2023
• Ind-Swift Laboratories Ltd QA officer
  2015 - 2017
• Crescent Therapeutic Limited Baddi Trainee Officer
  2011 - 2012

Education

• Glocal University Ph.D
  2018 - 2023
• Chandigarh College of Pharmacy Landran M.Pharmacy
  2012 - 2015
• Punjab Technical University M.Pharm
  2012 - 2014
• Dr. A.P.J. Abdul Kalam Technical University B.Pharm
  2007 - 2011
• Bharat Institute of Technology B.Pharm
  2007 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (40)

• Parkinson's Disease: Molecular Mechanisms, Metabolic Interactions, Biomarkers, and Emerging Therapeutic Targets
  Neurology and Clinical Neuroscience 2026 DOI: 10.1002/ncn3.70131
  +Save
• The Role of Artificial Intelligence in Diagnosing Malignant Tumors
  2025 DOI: 10.6084/m9.figshare.30609992
  +Save
• The Role of Artificial Intelligence in Parkinson's Disease: A Comprehensive Review
  2025 DOI: 10.6084/m9.figshare.30610061
  +Save
• The gut–brain axis: role of gut microbiota in neurological disease pathogenesis and pharmacotherapeutics
  Naunyn-Schmiedeberg's Archives of Pharmacology 2025 DOI: 10.1007/s00210-025-04776-7
  +Save
• Regenerative Medicine Unveiled: Principles, Technologies, and Clinical Breakthroughs in Tissue Regeneration
  Journal of Clinical Medicine of Kazakhstan 2025 DOI: 10.23950/jcmk/16880
  +Save
• Safety consideration and Hazardous Materials Management in Industries
  Journal of Engineering, Science and Sustainability 2025 DOI: 10.55559/jess.v1i1.507
  +Save
• Cerebrovascular enigma: Moyamoya disease etiology, identification, and management
  Journal of Experimental and Clinical Medicine 2024
  +Save
• The Role of Artificial Intelligence in Diagnosing Malignant Tumors
  Eurasian Journal of Medicine and Oncology 2024 DOI: 10.14744/EJMO.2024.24486
  +Save
• Erucic acid treatment in lipopolysaccharide-induced anxiety and depression using ADMET properties / behaviour paradigms / interleukins pathways in rats
  Regulatory Mechanisms in Biosystems 2024 DOI: 10.15421/022410
  +Save
• Novel Herbal formulations and their application in Arthritis
  ournal of Biointerface Research in Pharmaceutics and Applied Chemistry 2024 DOI: https://doi.org/10.55559/jjbrpac.v1i4.277
  +Save